カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

ヒト凍結乾燥狂犬病ワクチンの世界市場2022：曝露前ワクチン、曝露後ワクチン

◆英語タイトル：Global Human Lyophilized Rabies Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO19396 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：105 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ヒト凍結乾燥狂犬病ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒト凍結乾燥狂犬病ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒト凍結乾燥狂犬病ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・曝露前ワクチン、曝露後ワクチン

用途別セグメントは次のように区分されます。
・子供、大人

世界のヒト凍結乾燥狂犬病ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Bharat Biotech、Sanofi-Pasteur、Serum Institute of India、Bio-Med、Novartis Pharmaceuticals、Bavarian Nordic、Chengdu Kanghua Biological、Changchun Zhuoyi Biological、Liaoning Chengda Biotech、Liaoning Yisheng Biopharma、Beijing Minhai Biological、Shenzhen Weiguang、Ningbo Rongan Biological、Guangzhou Promise Biological

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト凍結乾燥狂犬病ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト凍結乾燥狂犬病ワクチンメーカーの企業概要、2019年～2022年までのヒト凍結乾燥狂犬病ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト凍結乾燥狂犬病ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒト凍結乾燥狂犬病ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒト凍結乾燥狂犬病ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト凍結乾燥狂犬病ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒト凍結乾燥狂犬病ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、ヒト凍結乾燥狂犬病ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヒト凍結乾燥狂犬病ワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：曝露前ワクチン、曝露後ワクチン
- 用途別分析（2017年vs2021年vs2028年）：子供、大人
- 世界のヒト凍結乾燥狂犬病ワクチン市場規模・予測
- 世界のヒト凍結乾燥狂犬病ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bharat Biotech、Sanofi-Pasteur、Serum Institute of India、Bio-Med、Novartis Pharmaceuticals、Bavarian Nordic、Chengdu Kanghua Biological、Changchun Zhuoyi Biological、Liaoning Chengda Biotech、Liaoning Yisheng Biopharma、Beijing Minhai Biological、Shenzhen Weiguang、Ningbo Rongan Biological、Guangzhou Promise Biological
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：曝露前ワクチン、曝露後ワクチン
・用途別分析2017年-2028年：子供、大人
・ヒト凍結乾燥狂犬病ワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト凍結乾燥狂犬病ワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト凍結乾燥狂犬病ワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト凍結乾燥狂犬病ワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト凍結乾燥狂犬病ワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Lyophilized Rabies Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Lyophilized Rabies Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Children accounting for % of the Human Lyophilized Rabies Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pre-Exposure Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Lyophilized Rabies Vaccine include Bharat Biotech, Sanofi-Pasteur, Serum Institute of India, Bio-Med, and Novartis Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Lyophilized Rabies Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pre-Exposure Vaccine
Post-Exposure Vaccine
Market segment by Application can be divided into
Children
Adults
The key market players for global Human Lyophilized Rabies Vaccine market are listed below:
Bharat Biotech
Sanofi-Pasteur
Serum Institute of India
Bio-Med
Novartis Pharmaceuticals
Bavarian Nordic
Chengdu Kanghua Biological
Changchun Zhuoyi Biological
Liaoning Chengda Biotech
Liaoning Yisheng Biopharma
Beijing Minhai Biological
Shenzhen Weiguang
Ningbo Rongan Biological
Guangzhou Promise Biological
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Lyophilized Rabies Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Lyophilized Rabies Vaccine, with price, sales, revenue and global market share of Human Lyophilized Rabies Vaccine from 2019 to 2022.
Chapter 3, the Human Lyophilized Rabies Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Lyophilized Rabies Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Lyophilized Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Lyophilized Rabies Vaccine.
Chapter 13, 14, and 15, to describe Human Lyophilized Rabies Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Human Lyophilized Rabies Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Lyophilized Rabies Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pre-Exposure Vaccine
1.2.3 Post-Exposure Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Lyophilized Rabies Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children
1.3.3 Adults
1.4 Global Human Lyophilized Rabies Vaccine Market Size & Forecast
1.4.1 Global Human Lyophilized Rabies Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Lyophilized Rabies Vaccine Sales in Volume (2017-2028)
1.4.3 Global Human Lyophilized Rabies Vaccine Price (2017-2028)
1.5 Global Human Lyophilized Rabies Vaccine Production Capacity Analysis
1.5.1 Global Human Lyophilized Rabies Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Human Lyophilized Rabies Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Lyophilized Rabies Vaccine Market Drivers
1.6.2 Human Lyophilized Rabies Vaccine Market Restraints
1.6.3 Human Lyophilized Rabies Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Lyophilized Rabies Vaccine Product and Services
2.1.4 Bharat Biotech Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Product and Services
2.2.4 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Human Lyophilized Rabies Vaccine Product and Services
2.3.4 Serum Institute of India Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bio-Med
2.4.1 Bio-Med Details
2.4.2 Bio-Med Major Business
2.4.3 Bio-Med Human Lyophilized Rabies Vaccine Product and Services
2.4.4 Bio-Med Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis Pharmaceuticals
2.5.1 Novartis Pharmaceuticals Details
2.5.2 Novartis Pharmaceuticals Major Business
2.5.3 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Product and Services
2.5.4 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bavarian Nordic
2.6.1 Bavarian Nordic Details
2.6.2 Bavarian Nordic Major Business
2.6.3 Bavarian Nordic Human Lyophilized Rabies Vaccine Product and Services
2.6.4 Bavarian Nordic Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Chengdu Kanghua Biological
2.7.1 Chengdu Kanghua Biological Details
2.7.2 Chengdu Kanghua Biological Major Business
2.7.3 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Product and Services
2.7.4 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Changchun Zhuoyi Biological
2.8.1 Changchun Zhuoyi Biological Details
2.8.2 Changchun Zhuoyi Biological Major Business
2.8.3 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Product and Services
2.8.4 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Liaoning Chengda Biotech
2.9.1 Liaoning Chengda Biotech Details
2.9.2 Liaoning Chengda Biotech Major Business
2.9.3 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Product and Services
2.9.4 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Liaoning Yisheng Biopharma
2.10.1 Liaoning Yisheng Biopharma Details
2.10.2 Liaoning Yisheng Biopharma Major Business
2.10.3 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Product and Services
2.10.4 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Beijing Minhai Biological
2.11.1 Beijing Minhai Biological Details
2.11.2 Beijing Minhai Biological Major Business
2.11.3 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Product and Services
2.11.4 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Shenzhen Weiguang
2.12.1 Shenzhen Weiguang Details
2.12.2 Shenzhen Weiguang Major Business
2.12.3 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Product and Services
2.12.4 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Ningbo Rongan Biological
2.13.1 Ningbo Rongan Biological Details
2.13.2 Ningbo Rongan Biological Major Business
2.13.3 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Product and Services
2.13.4 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Guangzhou Promise Biological
2.14.1 Guangzhou Promise Biological Details
2.14.2 Guangzhou Promise Biological Major Business
2.14.3 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Product and Services
2.14.4 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Lyophilized Rabies Vaccine Breakdown Data by Manufacturer
3.1 Global Human Lyophilized Rabies Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Lyophilized Rabies Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Lyophilized Rabies Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Human Lyophilized Rabies Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Human Lyophilized Rabies Vaccine Manufacturer Market Share in 2021
3.5 Global Human Lyophilized Rabies Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Lyophilized Rabies Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Lyophilized Rabies Vaccine Market Size by Region
4.1.1 Global Human Lyophilized Rabies Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Human Lyophilized Rabies Vaccine Revenue by Region (2017-2028)
4.2 North America Human Lyophilized Rabies Vaccine Revenue (2017-2028)
4.3 Europe Human Lyophilized Rabies Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Human Lyophilized Rabies Vaccine Revenue (2017-2028)
4.5 South America Human Lyophilized Rabies Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Human Lyophilized Rabies Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Lyophilized Rabies Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
5.3 Global Human Lyophilized Rabies Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Lyophilized Rabies Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
6.3 Global Human Lyophilized Rabies Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
7.2 North America Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
7.3 North America Human Lyophilized Rabies Vaccine Market Size by Country
7.3.1 North America Human Lyophilized Rabies Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
8.2 Europe Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
8.3 Europe Human Lyophilized Rabies Vaccine Market Size by Country
8.3.1 Europe Human Lyophilized Rabies Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Human Lyophilized Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Lyophilized Rabies Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Lyophilized Rabies Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
10.2 South America Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
10.3 South America Human Lyophilized Rabies Vaccine Market Size by Country
10.3.1 South America Human Lyophilized Rabies Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Human Lyophilized Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Lyophilized Rabies Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Lyophilized Rabies Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Lyophilized Rabies Vaccine
12.3 Human Lyophilized Rabies Vaccine Production Process
12.4 Human Lyophilized Rabies Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Lyophilized Rabies Vaccine Typical Distributors
13.3 Human Lyophilized Rabies Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト凍結乾燥狂犬病ワクチンの世界市場2022：曝露前ワクチン、曝露後ワクチン(Global Human Lyophilized Rabies Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒト凍結乾燥狂犬病ワクチンの世界市場2022：曝露前ワクチン、曝露後ワクチン

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp